NPY1R neurons are brain cells equipped with specialized receptors that respond to neuropeptide Y (NPY), a chemical messenger that helps regulate fundamental processes like appetite, mood, and stress responses. These neurons are scattered throughout critical brain regions including the hypothalamus, hippocampus, and cortex, where they act as key communication hubs in neural networks governing metabolism, emotion, and cognition.
In neurodegeneration research, NPY1R neurons have captured significant attention because they appear particularly vulnerable to disease processes. During Alzheimer's disease progression, these neurons suffer substantial damage, and NPY levels drop dramatically in affected brain regions—changes that correlate with both cognitive decline and the metabolic disruptions commonly seen in patients. The NPY signaling system also influences neuroinflammation and oxidative stress, two destructive processes that fuel neurodegeneration across multiple diseases.
This vulnerability extends beyond Alzheimer's to other neurodegenerative conditions including Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, suggesting that NPY1R neuron dysfunction may represent a common pathway in brain degeneration. Understanding whether protecting these neurons could slow disease progression or restore lost functions remains an active area of investigation with promising therapeutic implications.
NPY1R neurons are brain cells equipped with specialized receptors that respond to neuropeptide Y (NPY), a chemical messenger that helps regulate fundamental processes like appetite, mood, and stress responses. These neurons are scattered throughout critical brain regions including the hypothalamus, hippocampus, and cortex, where they act as key communication hubs in neural networks governing metabolism, emotion, and cognition.
In neurodegeneration research, NPY1R neurons have captured significant attention because they appear particularly vulnerable to disease processes. During Alzheimer's disease progression, these neurons suffer substantial damage, and NPY levels drop dramatically in affected brain regions—changes that correlate with both cognitive decline and the metabolic disruptions commonly seen in patients. The NPY signaling system also influences neuroinflammation and oxidative stress, two destructive processes that fuel neurodegeneration across multiple diseases.
This vulnerability extends beyond Alzheimer's to other neurodegenerative conditions including Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, suggesting that NPY1R neuron dysfunction may represent a common pathway in brain degeneration. Understanding whether protecting these neurons could slow disease progression or restore lost functions remains an active area of investigation with promising therapeutic implications.
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">NPY-Y1 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>
Npy Y1 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons expressing neuropeptide Y receptor 1 (NPY1R) represent a critical component of the neuropeptide Y signaling system in the central nervous system. NPY1R is a G protein-coupled receptor (GPCR) that binds neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) with high affinity. These receptors are widely distributed throughout the brain and play essential roles in regulating feeding behavior, energy homeostasis, anxiety, stress responses, and neuroprotection. [@npy2020]
<!-- multi-taxonomy-enrichment -->
NPY1R-expressing neurons are systematically catalogued across multiple standardized taxonomic databases that provide comprehensive classification frameworks for cell type identification. The Cell Ontology database maintains detailed annotations for these neurons under the identifier CL:0000197, accessible through both the European Bioinformatics Institute's Ontology Lookup Service and the OBO Foundry's direct ontological references. This standardized classification system enables researchers to maintain consistent nomenclature and cross-reference findings across different studies and institutional databases.
In addition to these foundational ontological resources, NPY1R neurons are extensively documented within specialized brain atlas databases that focus specifically on neural cell populations. The Allen Brain Cell Atlas provides detailed spatial and molecular characterization data for these cell types, offering high-resolution mapping of their distribution patterns throughout the central nervous system. This is further supported by single-cell genomics platforms such as CellxGene Census, which aggregates transcriptomic profiles from multiple research studies to create comprehensive molecular signatures for NPY1R-positive cell populations.
The Human Cell Atlas represents another critical resource for understanding the broader biological context of these neurons within human tissue architecture. This global initiative systematically maps all human cell types, including NPY1R neurons, providing researchers with standardized reference datasets that facilitate cross-study comparisons and enable more robust experimental validation. Together, these database resources create an interconnected knowledge network that supports both basic research investigations and translational studies focused on NPY1R neuronal function in health and disease.
NPY1R-expressing neurons are found in several key brain regions: [@neuropeptide2019]
NPY1R is a 36-kDa GPCR belonging to the NPY receptor family (Y1 subtype). The receptor: [@npyr2021]
NPY1R neurons mediate diverse neurophysiological functions that span multiple critical brain circuits and regulatory systems. [@npyr2018] These neurons play particularly important roles in energy homeostasis, where they integrate key metabolic signals including leptin, insulin, and ghrelin to coordinate appropriate physiological responses. Within the hypothalamus, NPY1R neurons promote satiety signaling and actively regulate both food intake and energy expenditure. This metabolic control extends beyond central regulation, as these neurons also modulate white adipose tissue metabolism through sympathetic outflow pathways.
In addition to their metabolic functions, NPY1R neurons are integral to anxiety and stress response systems throughout the brain. These neurons mediate the anxiogenic effects of NPY within the amygdala, while simultaneously modulating HPA axis activity and corticosterone release. This dual role is further supported by their interactions with CRH and corticosterone systems, which collectively influence both fear conditioning and extinction processes. The positioning of NPY1R neurons within these stress circuits explains why they serve as critical mediators between emotional states and physiological responses.
NPY1R neurons also contribute significantly to cognitive function through their actions in the hippocampus and related brain regions. These neurons modulate synaptic plasticity in the hippocampus, thereby influencing fundamental learning and memory processes. This cognitive influence occurs through their regulation of hippocampal excitability, which in turn protects against excitotoxicity that could otherwise impair neuronal function.
The neuroprotective properties of NPY1R neurons represent another crucial aspect of their physiological roles. These neurons activate anti-apoptotic signaling through the PI3K/Akt pathway, providing cellular protection against various forms of stress and injury. This protective mechanism is further enhanced by their ability to reduce calcium influx during periods of excitotoxic stress, preventing the cellular damage that would otherwise result from excessive calcium accumulation. NPY1R neurons also modulate inflammatory responses in microglia, creating a more favorable environment for neuronal survival. This explains why these neurons consistently promote neuronal survival in experimental models of neurodegeneration, highlighting their potential therapeutic importance in neurodegenerative diseases.
In Alzheimer's Disease (AD), NPY levels are notably altered in affected brains, with reduced NPY expression observed in certain regions. This reduction is particularly significant because NPY1R signaling appears to protect against amyloid-beta toxicity, suggesting that diminished NPY function may exacerbate neurodegeneration. This protective role is further supported by genetic studies showing that polymorphisms in the NPY1R gene are associated with AD risk in some populations. Given these findings, NPY1R agonists are being investigated for their therapeutic potential, as they may offer neuroprotective effects against the progression of Alzheimer's disease.
Similarly, Parkinson's Disease (PD) involves disruption of NPY1R neuron function, particularly those located in the basal ganglia that modulate dopaminergic signaling. Altered NPY expression has been consistently observed in PD brains, which may explain the motor dysfunction characteristic of this condition. In addition to their role in disease pathogenesis, NPY1R neurons appear to play a potential role in regulating motor function and may be involved in the development of levodopa-induced dyskinesias, a common complication of PD treatment.
The involvement of NPY1R neurons extends beyond neurodegenerative diseases to psychiatric conditions, where dysregulated NPY1R signaling has been associated with stress vulnerability in depression and anxiety disorders. Interestingly, NPY1R antagonists have shown anxiolytic effects in preclinical models, making these receptors an attractive target for novel antidepressant development.
NPY1R neurons also play crucial roles in metabolic regulation, with NPY1R antagonists currently being explored as anti-obesity agents. These neurons contribute to leptin resistance and metabolic syndrome through complex interactions with the melanocortin system, highlighting their importance in maintaining energy homeostasis.
In epilepsy research, NPY1R signaling has demonstrated anti-convulsant properties, which is consistent with observations of decreased NPY1R expression in epileptic tissue. This relationship has led to the investigation of gene therapy approaches using NPY delivery as a potential treatment strategy for seizure disorders, representing an innovative therapeutic avenue that targets the underlying neurotransmitter imbalances in epilepsy.
NPY1R expression serves as a biomarker:
The study of Npy Y1 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Comprehensive molecular and pharmacological information about NPY1R can be accessed through several specialized databases. The UniProt database provides detailed protein sequence and functional data for NPY1R under accession P25929, offering insights into the receptor's structure and biochemical properties. This molecular foundation is further supported by pharmacological data available through the IUPHAR Guide to Pharmacology, which catalogs NPY1R as receptor ID 344 and includes extensive information about ligand interactions, tissue distribution, and therapeutic targets.
In addition to these specialized resources, researchers can access the broader scientific literature through PubMed to explore current research developments and clinical findings related to NPY1R neurons. This bibliographic access is complemented by comprehensive gene-centric information available through GeneCards, which consolidates data about the NPY1R gene including expression patterns, associated diseases, and functional annotations that are particularly relevant for understanding the role of these neurons in neurodegeneration research.